Find the latest pharmaceutical market place for formulations enquiry about Nebivolol on PharmaCompass.com.

Various Finished Dosage Formulations needed in Ukraine [ENA13531]

A company that manufactures generic and original medicines in such forms as injections in vials, tablets, capsules, ointments, gels, and suspensions is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The required quantity is 20,000 units for first year, 35,000 units for second year, 65,000 units for third year, 100,000 unit for fourth year & 130,000 units for fifth year. The suppliers must support this enquiry with CTD dossier, EU GMP/ USFDA/ Australian GMP/ Japan GMP/ South Korea GMP. The tablets are required in blister packaging.
1. Nebivolol (5 mg) + Amlodipine (2.5 mg) Tablets
2. Nebivolol (5 mg) + Amlodipine (5 mg) Tablets

Reply

05 May 2022

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA09944]

Multi-Profile Hospital for active treatment "Dr Stoycho Hristov" EOOD is looking for supplies of Various Finished Dosage Formulations. The deadline is 12-April-2021.
1. Metoprolol (50 mg) Prolonged Release Tablets. The required quantity is 210 units.
2. Bisoprolol (5 mg) Tablets. The required quantity is 1,500 units.
3. Nebivolol (5 mg) Tablets. The required quantity is 1,500 units.
4. Amlodipine (5 mg) Tablets. The required quantity is 2,100 units.
5. Lercanidipine (10 mg) Tablets. The required quantity is 900 units.
6. Pentoxifylline (400 mg) Tablets. The required quantity is 2,400 units.
7. Lisinopril (10 mg) Tablets. The required quantity is 300 units.
8. Valsartan (240 mg) Tablets. The required quantity is 160 units.
9. Candesartan Cilexetil (16 mg) Tablets. The required quantity is 900 units.
10. Irbesartan (150 mg) Tablets. The required quantity is 300 units.

Reply

15 Mar 2021

Various finished formulations needed in Kuwait [ENA05314]

Kuwait Medicament, A pharmaceutical company specialized in medicinal marketing and distribution in the Kuwait pharma market is looking for suppliers of finished formulations mentioned below. Interested suppliers can contact them via Email: malazmi@kuwait-medicament.com.
1. Labetalol (100 mg) and (200 mg) tablets
2. Nebivolol (5 mg) tablets
3. Metformin XR (500 mg) and (1000 mg) tablets
4. Metolazone (5 mg) tablets
5. Aldactone (25 mg) tablets
6. Potassium Chloride (600 mg) and (750 mg) tablets.

Reply

01 Oct 2019

Omeprazole capsules , Memantine HCl tablets and other formulations needed in China [ENA04112]

One of the leading pharmaceutical distributors in China is looking for suppliers/manufacturers of below formulations for tech transfer:
1. Omeprazole Gastro-resistant- 10 mg, 20 mg & 40 mg Capsule
2. Irbesartan + Hydrochlorothiazide- 150/12.5 mg, 300/12.5 mg & 300/25 mg Tablet
3. Memantine HCL- 20 mg & 10 mg Tablet USP
4. Metformin Coated- 1,000 mg, 850 mg & 500 mg Tablet
5. Montelukast- 10 mg Tablet
6. Montelukast- 4 mg & 5 mg Chewable Tablet
7. Nifedipine Extended Release- 30 mg & 60 mg Tablets
8. Orlistat- 120 mg Capsules
9. Pioglitazone HCl Immediate Release- 15 mg, 30 mg & 45 mg Tablets USP
10. Telmisartan- 80 mg, 40 mg & 20 mg Tablets
11. Ramipril- 10 mg, 5 mg, 2.5 mg & 1.25 mg Tablets
12. Telmisartan and Amlodipine- 80/10 mg, 80/5, 40/10 & 40/5 mg Tablets
13. Nebivolol- 2.5 mg, 5 mg, 10 mg & 20 mg Tablets.

Reply

08 May 2019

Nifedipine tablets, Orlistat capsules and other formulations needed in China [ENA03786]

One of the leading pharmaceutical distributors in China is looking for suppliers/manufacturers of below formulations with tech transfer:
1. Nifedipine extended-release tablets 30 mg, 60 mg
2. Orlistat capsules 120 mg
3. Pioglitazone HCl USP tablet 15mg, 30mg, 45 mg (immediate release)
4. Telmisartan tablets 80mg, 40mg, 20mg
5. Ramipril tablets 10mg, 5mg, 2.5mg, 1.25 mg
6. Telmisartan and Amlodipine tablets 80/10 mg, 80/5, 40/10, 40/5 mg
7. Nebivolol tablets 2.5 mg, 5 mg, 10 mg & 20 mg

Reply

29 Mar 2019

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.